RECRUITINGOBSERVATIONAL
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Fenotipado Molecular De Pacientes Con Migraña Según Edad Y Sexo a Través De La Cuantificación De CGRP En Saliva Para Realizar Medicina De Precisión: Estudio FAST
About This Trial
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.
Who May Be Eligible (Plain English)
Who May Qualify:
- Migraine patients according to ICHD-3 criteria
- Healthy controls paired to patient age and sex, without headache and without first degree family history of headache.
Who Should NOT Join This Trial:
- Presence of any major medical or neurological illness.
- Presence of any salivary gland malfunction.
- Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment.
- Active migraine preventive treatment.
- Pregnant or breastfeeding female.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Migraine patients according to ICHD-3 criteria
* Healthy controls paired to patient age and sex, without headache and without first degree family history of headache.
Exclusion Criteria:
* Presence of any major medical or neurological illness.
* Presence of any salivary gland malfunction.
* Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment.
* Active migraine preventive treatment.
* Pregnant or breastfeeding female.
Treatments Being Tested
DIAGNOSTIC_TEST
Saliva test
Sampling of CGRP in saliva and DNA blood test and sex hormones blood test.
Locations (1)
Vall d'Hebron University Hospital
Barcelona, Barcelona, Spain